Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery.

Buckner TW, Leavitt AD, Ragni M, Kempton CL, Eyster ME, Cuker A, Lentz SR, Ducore J, Leissinger C, Wang M, Key NS.

Thromb Haemost. 2016 Mar 24;116(1). [Epub ahead of print]

PMID:
27009484
2.

End-Stage Renal Disease From Cast Nephropathy in a Teenager With Neuroendocrine Carcinoma.

Butani L, Ducore J.

J Pediatr Hematol Oncol. 2016 Jul;38(5):e177-9. doi: 10.1097/MPH.0000000000000556.

PMID:
26989910
3.

Dust metal loadings and the risk of childhood acute lymphoblastic leukemia.

Whitehead TP, Ward MH, Colt JS, Dahl G, Ducore J, Reinier K, Gunier RB, Katharine Hammond S, Rappaport SM, Metayer C.

J Expo Sci Environ Epidemiol. 2015 Nov-Dec;25(6):593-8. doi: 10.1038/jes.2015.9. Epub 2015 Mar 4.

4.

Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B.

Ducore JM, Miguelino MG, Powell JS.

Expert Rev Hematol. 2014 Oct;7(5):559-71. doi: 10.1586/17474086.2014.951322. Epub 2014 Aug 21.

PMID:
25142322
5.

WARM N COLD: malignant and benign renal tumors in children.

Sanchez TR, Ducore J, Balagtas J, Molloy C, Wootton-Gorges SL.

Emerg Radiol. 2014 Jun;21(3):261-9. doi: 10.1007/s10140-014-1202-8. Epub 2014 Feb 26. Review.

PMID:
24570120
6.

Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype.

Metayer C, Zhang L, Wiemels JL, Bartley K, Schiffman J, Ma X, Aldrich MC, Chang JS, Selvin S, Fu CH, Ducore J, Smith MT, Buffler PA.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1600-11. doi: 10.1158/1055-9965.EPI-13-0350. Epub 2013 Jul 12.

7.

Children and adolescents with ALL are taller than expected at diagnosis.

Huang T, Ducore JM.

J Pediatr Hematol Oncol. 2014 Jan;36(1):16-21. doi: 10.1097/MPH.0b013e31829bcb10.

PMID:
23799523
8.

Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2013 Feb;42(2):741-8. doi: 10.3892/ijo.2012.1734. Epub 2012 Dec 12.

9.

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Astermark J, Donfield SM, Gomperts ED, Schwarz J, Menius ED, Pavlova A, Oldenburg J, Kessing B, DiMichele DM, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Blood. 2013 Feb 21;121(8):1446-54. doi: 10.1182/blood-2012-06-434803. Epub 2012 Dec 6.

10.

Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2012 Dec;41(6):2207-12. doi: 10.3892/ijo.2012.1650. Epub 2012 Oct 4.

11.

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study Combined Cohort.

Haemophilia. 2013 Jan;19(1):113-8. doi: 10.1111/hae.12004. Epub 2012 Sep 7.

12.

Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2012 Apr;40(4):1277-84. doi: 10.3892/ijo.2011.1316. Epub 2011 Dec 22.

13.

Thrombotic thrombocytopenic purpura in a child with systemic lupus erythematosus.

Thampi S, Salmi D, Imashuku S, Ducore J, Satake N.

J Pediatr Hematol Oncol. 2011 Apr;33(3):221-3. doi: 10.1097/MPH.0b013e318208425d.

PMID:
21336165
14.

Diagnostic X-rays and risk of childhood leukaemia.

Bartley K, Metayer C, Selvin S, Ducore J, Buffler P.

Int J Epidemiol. 2010 Dec;39(6):1628-37. doi: 10.1093/ije/dyq162. Epub 2010 Oct 1.

15.

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.

Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK; Children’s Oncology Group.

N Engl J Med. 2010 Sep 30;363(14):1313-23. doi: 10.1056/NEJMoa1001527.

17.

Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11).

Zunino SJ, Storms DH, Ducore JM.

Cancer Lett. 2010 Oct 1;296(1):49-54. doi: 10.1016/j.canlet.2010.03.017. Epub 2010 Apr 9.

18.

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.

Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA; HTCN Study Investigators.

Haemophilia. 2009 Jul;15(4):918-25. doi: 10.1111/j.1365-2516.2009.02025.x. Epub 2009 Apr 7.

PMID:
19473418
19.

Risk factors for the development of obesity in children surviving ALL and NHL.

Gofman I, Ducore J.

J Pediatr Hematol Oncol. 2009 Feb;31(2):101-7. doi: 10.1097/MPH.0b013e31818c0120.

PMID:
19194192
20.

Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells.

Zunino SJ, Ducore JM, Storms DH.

Cancer Lett. 2007 Aug 28;254(1):119-27. Epub 2007 Apr 30.

PMID:
17470383
Items per page

Supplemental Content

Loading ...
Write to the Help Desk